Our customers' Feedback
Search:
Perform search
Categories list

Generic Janumet

News
Janumet
Janumet photo

Generic Janumet (Sitagliptin Metformin)

Diabetes

PackagePricePer PillSavingsOrder
500mg + 50mg × 14 pills$39.95$2.85Add to cart
500mg + 50mg × 28 pills$74.95$2.68$4.95Add to cart
500mg + 50mg × 56 pills$139.95$2.50$19.85Add to cart
500mg + 50mg × 84 pills$199.95$2.38$39.75Add to cart
500mg + 50mg × 112 pills$249.95$2.23$69.65Add to cart

PackagePricePer PillSavingsOrder
1000mg + 50mg × 14 pills$44.95$3.21Add to cart
1000mg + 50mg × 28 pills$79.95$2.86$9.95Add to cart
1000mg + 50mg × 56 pills$149.95$2.68$29.85Add to cart
1000mg + 50mg × 84 pills$209.95$2.50$59.75Add to cart
1000mg + 50mg × 112 pills$259.95$2.32$99.65Add to cart

Most popular quantity.
Januvia
$ 3.52
Generic Januvia
(Sitagliptin Phosphate 25/50/100mg)
Metaglip
$ 0.50
Generic Metaglip
(Glipizide - Metformin 2.5mg + 250mg)
Micronase
$ 0.44
Generic Micronase
(Glyburide(glibenclamide) 1.25/2.5/5mg)
Onglyza
$ 3.21
Generic Onglyza
(Saxagliptin 5mg)
Prandin
$ 0.83
Generic Prandin
(Repaglinide 0.5/1/2mg)
Precose
$ 0.96
Generic Precose
(Acarbose 25/50mg)
Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • Januvia and Janumet: Merck's Blockbuster Diabetes Drugs - Market Realist

    Januvia and Janumet: Merck's Blockbuster Diabetes DrugsMarket RealistJanuvia and Janumet are Merck & Co.

  • Sanofi SA (ADR) and Diabetes: Things Are Not Working Out - Business Finance News

    Business Finance NewsSanofi SA (ADR) and Diabetes: Things Are Not Working OutBusiness Finance NewsThe drugmaker is mainly dependent upon its Januvia and Janumet combo pill.

  • Januvia and Janumet: Merck's Blockbuster Diabetes Products - Market Realist

    Januvia and Janumet: Merck's Blockbuster Diabetes ProductsMarket RealistJanuvia and Janumet are two blockbuster drugs in Merck & Co.

  • Merck: Good Time to Buy - Barron's

    Barron'sMerck: Good Time to BuyBarron'sOn a constant currency basis, the company's two Type 2 diabetes treatments, Januvia and Janumet, saw sales climb 4%.

  • Merck's Mixed Q1 Results Are Marred By 1 Disappointing Drug Debut - Motley Fool

    Motley FoolMerck's Mixed Q1 Results Are Marred By 1 Disappointing Drug DebutMotley FoolFor example, after a dismal Q4 report showed a 6% decline in operating sales of Januvia in Q1, notoriously the slowest quarter of the year for Januvia/Janumet, Januvia/Janumet sales expanded by 1%.

    Copyright © cheapgenerics24.com